Sep 12, 2018 8:45 am EDT Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain
Aug 9, 2018 4:20 pm EDT Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights
Jul 26, 2018 8:30 am EDT Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer
Jun 6, 2018 8:45 am EDT Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare Conference
May 31, 2018 8:45 am EDT Abeona Therapeutics Announces Opening of Commercial Gene & Cell Therapy Manufacturing Facility in Ohio
May 18, 2018 9:25 am EDT Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting
May 17, 2018 9:20 am EDT Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting
May 14, 2018 8:15 am EDT Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
May 11, 2018 8:15 am EDT Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights
